Deciphera Pharmaceuticals, Inc. (DCPH)
Deciphera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering important new medicines to patients for the treatment of cancer. The firm designs a drug candidate, DCC-2618, to inhibit the full spectrum of mutant or amplified KIT and PDGFRa kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors. The company was founded by Peter A. Petillo and Daniel L. Flynn in 2003 and is headquartered in Waltham, MA.
Address
200 SMITH STREET
WALTHAM, MA 02451
Founded
2003
Number of Employees
355
Website
http://www.deciphera.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)